Tequin, an antibiotic which can cause serious blood sugar complications, is being pulled from the market by manufacturer Bristol-Myers Squibb.
Increased Warnings
In February of this year, the U.S. FDA required increased warnings on the label of the drug. It is most dangerous to diabetics, the elderly, and those with kidney disease.
A Recall Urged
However, while Bristol-Myers Squibb will stop making and selling the drug, currently available stocks will not be recalled.
There have been 20 deaths and over 150 hospitalizations associated with Tequin since January 2000. The public interest group Public Citizen has petitioned for the drug to be completely recalled from the market.
MSNBC May 1, 2006
Top of Document